🚀 MGI Tech Sells Complete Genomics to Swiss Rockets for $50 Million
#MGITech #CompleteGenomics #SwissRockets #Genomics #SequencingTechnology #Jin10 #LicensingAgreement #StandardMPS #RevenueBoost #OperationalEfficiency
MGI Tech, a wholly-owned subsidiary of 华大智造, announced the sale of its subsidiary, Complete Genomics, Inc., to Swiss Rockets AG for approximately $50 million. According to Jin10, the transaction involves divesting Complete Genomics' assets and liabilities. Additionally, MGI US LLC and CGI have signed an amended licensing agreement with Swiss Rockets, granting exclusive rights to the StandardMPS sequencing technology in the U.S. and Canada, along with a general license for sequencing technology. This deal is expected to significantly enhance the company's direct revenue and improve cash flow, boosting overall profitability and operational efficiency.#MGITech #CompleteGenomics #SwissRockets #Genomics #SequencingTechnology #Jin10 #LicensingAgreement #StandardMPS #RevenueBoost #OperationalEfficiency
🚀 MGI to Divest Complete Genomics to Swiss Rockets AG for $50 Million
#MGI #CompleteGenomics #SwissRocketsAG #biotechnology #genomics #businessrealignment #strategicmove #assetoptimization #marketconsolidation
MGI has announced its decision to sell its entire stake in Complete Genomics to Swiss Rockets AG for approximately $50 million. Bloomberg posted on X, highlighting this strategic move as part of MGI's broader business realignment. The transaction is expected to enhance MGI's focus on its core operations while allowing Swiss Rockets AG to expand its portfolio in the genomics sector. The deal underscores the ongoing consolidation in the biotechnology industry, as companies seek to optimize their assets and strengthen their market positions.#MGI #CompleteGenomics #SwissRocketsAG #biotechnology #genomics #businessrealignment #strategicmove #assetoptimization #marketconsolidation